Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

NCT01944709 is registered in ClinicalTrials.gov with Prof. Dr. Silke Gillessen as lead sponsor.

NCT NCT01944709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma
Lead sponsor
Prof. Dr. Silke Gillessen
Phase
Phase 1/2
Overall status
Terminated
Start date
August 31, 2006
Completion date
December 31, 2010
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma